AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

AMODIAQUINE

9 registrations across 3 African markets— 6 active

Markets with AMODIAQUINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
CAMOSUNATE PAEDIATRIC POWDER
POWDER/1 X 6 SATCHETS X 10 BOXES
🇳🇬NigeriaGENEITH PHARMACEUTICALS LTD NO. 12expiredNov 2021
AMODIAQUINE 50MG SUSPENSION BUVABLE FLACON DE 60ML🇨🇮Côte d'IvoireGLENMARK PHARMACEUTICALS LIMITEDexpiredAug 2011
FLAVOQUINE 25MG/5ML SUSPENSION BUVABLE FLACON DE 60 ML🇨🇮Côte d'IvoireCIPHARMexpiredDec 2009
CAMOQUIN
comprimé / 200 mg
🇸🇳SenegalPARKE DAVISactive
AMODIAQUINE
comprimé / 200 mg
🇸🇳SenegalSIPOA RHONE POULENC RORERactive
AMODIAQUINE
comprimé / 20 mg
🇸🇳SenegalNESTOR PHARMACEUTICALS LIMITEDactive
CAMOQUIN
comprimé / 200 mg
🇸🇳SenegalPARKE DAVISactive
AMODIAQUINE GUILIN
comprimé / 150 mg
🇸🇳SenegalGUILIN PHARMAactive
CAMOQUIN
comprimé / 600 mg
🇸🇳SenegalPARKE DAVISactive

AMODIAQUINE in Africa — Regulatory Overview

AMODIAQUINE is registered across 3 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, Côte d'Ivoire, Nigeria. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 6 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.